Use of drospirenone for preventing high blood pressure in prehypertensive patients

Details for Australian Patent Application No. 2007251707 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Hanes, Vladimir

Agent Davies Collison Cave

Pub. Number AU-A-2007251707

PCT Pub. Number WO2007/131805

Priority 60/800,834 17.05.06 US

Filing date 17 May 2007

Wipo publication date 22 November 2007

International Classifications

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/566 (2006.01) - having an oxo group in position 17, e.g. oestrone

A61K 31/585 (2006.01)

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/131805 Priority application(s): WO2007/131805

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007251711-Device for the regeneration and prevention of degeneration of the cartilaginous tissue and subchrondral bone and the proliferation of chondrocytes by means of a pulsed electromagnetic field

2007251696